Mustafa Sara, Paul Ryan, Keenan Rawiri, Magliano Dianna, Chepulis Lynne
Medical Research Centre, Te Huataki Waiora School of Health, University of Waikato, Hamilton, New Zealand.
Te Whatu Ora Health New Zealand, Hamilton, New Zealand.
J Diabetes Res. 2024 Dec 10;2024:9968545. doi: 10.1155/jdr/9968545. eCollection 2024.
The prevalence of diabetes mellitus among children, youth, and young adults is increasing, yet limited information is known about the characteristics and management of these groups with Type 1 (T1D) and Type 2 (T2D) diabetes in primary care. The aim of the study is to explore the characteristics of people with T1D and T2D aged < 25 years across the Auckland and Waikato regions of New Zealand. : Sociodemographic and clinical data were collected from electronic primary care records (February 2021-July 2022) of four primary healthcare organisations, with medication data sourced from the National Pharmaceutical dataset. Associations between sociodemographic and clinical data were conducted using chi-square and nonparametric ANOVA. Of 1198 patients, 72% had T1D and 28% had T2D. People with T1D were evenly distributed by gender but more commonly of European descent (66.7%) compared to other ethnic groups. A higher proportion of T2D was observed in females (58.2%) compared to males (41.6%) and among Māori (38.2% vs. 20.3% European; < 0.001). Over 95% of individuals with T2D were overweight/obese. Overall, 9.5% and 23.9% of individuals with T1D and T2D, respectively, were at target for HbA1c, though median HbA1c was higher for Māori and Pasifika compared to other ethnicities ( < 0.001). In T1D, 94.7% of individuals were dispensed insulin and 7.5% and 4.4% were dispensed angiotensin-converting enzyme (ACE) inhibitors and statins, respectively. In T2D, medication use included metformin (84.9%), insulin (76.1%), and SGLT2i/GLP1RA (59.5%). : The increasing burden of diabetes among young individuals in New Zealand underscores the urgent need for comprehensive strategies to address obesity and socioeconomic disparities, especially among marginalised communities. Addressing socioeconomic factors such as affordable housing, living wages, and healthcare access may be important for improving diabetes outcomes, as these factors significantly influence overall childhood health and well-being.
儿童、青少年及青年成年人中糖尿病的患病率正在上升,但在初级保健中,关于这些1型糖尿病(T1D)和2型糖尿病(T2D)群体的特征及管理的信息却很有限。本研究的目的是探究新西兰奥克兰和怀卡托地区25岁以下的T1D和T2D患者的特征。:从四个初级医疗保健机构的电子初级保健记录(2021年2月至2022年7月)中收集社会人口统计学和临床数据,用药数据来自国家药品数据集。使用卡方检验和非参数方差分析对社会人口统计学和临床数据之间的关联进行分析。在1198名患者中,72%患有T1D,28%患有T2D。T1D患者的性别分布均匀,但与其他种族群体相比,欧洲血统的患者更为常见(66.7%)。与男性(41.6%)相比,女性中T2D的比例更高(58.2%),在毛利人中也更高(38.2%对欧洲裔的20.3%;<0.001)。超过95%的T2D患者超重/肥胖。总体而言,T1D和T2D患者中分别有9.5%和23.9%的患者糖化血红蛋白(HbA1c)达标,不过与其他种族相比,毛利人和太平洋岛民的HbA1c中位数更高(<0.001)。在T1D患者中,94.7%的患者使用胰岛素,7.5%和4.4%的患者分别使用血管紧张素转换酶(ACE)抑制剂和他汀类药物。在T2D患者中,用药包括二甲双胍(84.9%)、胰岛素(76.1%)和钠-葡萄糖协同转运蛋白2抑制剂/胰高血糖素样肽1受体激动剂(SGLT2i/GLP1RA,59.5%)。:新西兰年轻人中糖尿病负担的增加凸显了制定全面策略以应对肥胖和社会经济差异的迫切需求,尤其是在边缘化社区。解决诸如经济适用房、生活工资和医疗保健可及性等社会经济因素可能对改善糖尿病治疗效果很重要,因为这些因素会显著影响儿童的整体健康和福祉。